A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Evan M. Hersh, M. Del Vecchio, M. P. Brown, R. Kefford, C. Loquai, A. Testori, S. Bhatia, R. Gutzmer, R. Conry, A. Haydon, C. Robert, S. Ernst, J. Homsi, J. J. Grob, K. Kendra, S. S. Agarwala, M. Li, A. Clawson, C. Brachmann, M. KarnoubI. Elias, M. F. Renschler, A. Hauschild

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences